Avanos Medical Inc Quick Ratio (AVNS) starting from the first quarter 2026 to first quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Avanos Medical Inc   (NYSE: AVNS)

Avanos Medical Inc 's Quick Ratio

AVNS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the first quarter 2026, Quick Ratio deteriorated to 0.54 below Avanos Medical Inc 's average Quick Ratio.

Within Medical Equipment & Supplies industry 35 other companies have achieved higher Quick Ratio than Avanos Medical Inc in first quarter 2026. While Quick Ratio total ranking has improved so far during the Q1 2026 to 572, from total ranking in the fourth quarter 2025 at 2222.

Explain Quick Ratio?
How much Cash & cash equivalents AVNS´s has?
What are AVNS´s Current Liabilities?




AVNS Quick Ratio (Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
(Mar 31 2025)
Q1
Y / Y Current Liabilities Change -4.73 % 1.29 % -30.52 % -35.91 % -34.54 %
Y / Y Cash & cash equivalent Change -32.37 % -16.62 % -20.79 % -2.06 % 27.97 %
Quick Ratio MRQ 0.54 0.57 0.51 0.73 0.76
AVNS's Total Ranking # 572 # 2222 # 1411 # 1239 # 1780
Seq. Current Liabilities Change -23.06 % 13.44 % 11.43 % -2.05 % -18.19 %
Seq. Cash & cash equivalent Change -26.95 % 27.38 % -21.93 % -6.91 % -9.94 %



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 36
Healthcare Sector # 144
Overall Market # 572


Quick Ratio Statistics
High Average Low
1.67 0.71 0.21
(Jun 30 2019)   (Sep 30 2014)




Financial Statements
Avanos Medical Inc 's Current Liabilities $ 121 Millions Visit AVNS's Balance sheet
Avanos Medical Inc 's Cash & cash equivalent $ 66 Millions Visit AVNS's Balance sheet
Source of AVNS's Sales Visit AVNS's Sales by Geography


Cumulative Avanos Medical Inc 's Quick Ratio

AVNS's Quick Ratio for the trailling 12 Months

AVNS Quick Ratio

(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
(Mar 31 2025)
12 Months
Y / Y Current Liabilities TTM Growth -19.92 % -26.33 % -32.67 % -21.13 % -6.34 %
Y / Y Cash & cash equivalent TTM Growth -18.06 % -4.69 % 6.03 % 5.84 % 9.51 %
Quick Ratio TTM 0.59 0.64 0.67 0.63 0.57
Total Ranking TTM # 2859 # 3118 # 2065 # 3146 # 3398
Seq. Current Liabilities TTM Growth -1.1 % 0.37 % -10.05 % -10.31 % -9.02 %
Seq. Cash & cash equivalent TTM Growth -9.03 % -4.9 % -4.82 % -0.49 % 5.81 %


On the trailing twelve months basis In spite of the year on year decrease in AVNS's Current Liabilities to $120.80 millions, cumulative Quick Ratio to 0.59 below the AVNS average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 171 other companies have achieved higher Quick Ratio than Avanos Medical Inc . While Quick Ratio overall ranking has improved so far to 2859, from total ranking during the twelve months ending fourth quarter 2025 at 3118.

Explain Quick Ratio?
How much Cash & cash equivalents AVNS´s has?
What are AVNS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 172
Healthcare Sector # 803
Within the Market # 2859


trailing twelve months Quick Ratio Statistics
High Average Low
1.5 0.72 0.34
(Jun 30 2019)   (Mar 31 2017)




Companies with similar Quick Ratio in the quarter ending Mar 31 2026, within Medical Equipment & Supplies Industry Quick RatioMar 31 2026 MRQ Cash & cash equivalentMar 31 2026 MRQ Current Liabilities
Intelligent Bio Solutions Inc   1.49 $ 6.862  Millions$ 4.611  Millions
Escalon Medical Corp   1.47 $ 3.343  Millions$ 2.266  Millions
Envista Holdings Corporation  1.38 $ 1,082.800  Millions$ 786.600  Millions
Qhslab Inc   1.32 $ 0.362  Millions$ 0.275  Millions
Globus Medical Inc   1.31 $ 629.851  Millions$ 482.463  Millions
Carlisle Companies Incorporated  1.28 $ 771.300  Millions$ 601.300  Millions
Alphatec Holdings Inc   1.25 $ 139.912  Millions$ 111.566  Millions
Resmed Inc   1.23 $ 1,660.513  Millions$ 1,351.210  Millions
Vicarious Surgical Inc  1.10 $ 3.682  Millions$ 3.348  Millions
Orthopediatrics Corp  1.10 $ 48.809  Millions$ 44.425  Millions
Precision Optics Corporation Inc   1.05 $ 10.680  Millions$ 10.193  Millions
Lifeward ltd   1.00 $ 11.422  Millions$ 11.418  Millions
Sanara Medtech Inc   0.99 $ 13.594  Millions$ 13.701  Millions
Koru Medical Systems Inc   0.99 $ 8.768  Millions$ 8.852  Millions
Lucid Diagnostics Inc   0.98 $ 27.876  Millions$ 28.477  Millions
West Pharmaceutical Services Inc   0.90 $ 521.400  Millions$ 580.000  Millions
Medline Inc   0.88 $ 2,236.000  Millions$ 2,536.000  Millions
Stryker Corp  0.87 $ 3,004.000  Millions$ 3,452.000  Millions
Haemonetics Corporation  0.87 $ 245.440  Millions$ 282.599  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.86 $ 6.900  Millions$ 8.058  Millions
Neuronetics Inc   0.83 $ 18.964  Millions$ 22.863  Millions
Integra Lifesciences Holdings Corp  0.83 $ 265.502  Millions$ 321.291  Millions
Establishment Labs Holdings Inc   0.82 $ 68.101  Millions$ 83.153  Millions
Lifestance Health Group Inc   0.81 $ 194.797  Millions$ 239.732  Millions
Medtronic Plc  0.80 $ 9,313.000  Millions$ 11,658.000  Millions
Glucotrack Inc   0.79 $ 3.929  Millions$ 4.975  Millions
Invo Fertility Inc   0.77 $ 4.905  Millions$ 6.356  Millions
Lensar Inc   0.76 $ 13.495  Millions$ 17.799  Millions
Pro dex Inc   0.75 $ 10.979  Millions$ 14.636  Millions
Cerus Corporation  0.75 $ 80.425  Millions$ 107.383  Millions

Date modified: 2026-09-26T07:01:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.